Literature DB >> 5687529

Familial erythrocytosis. A description of three families, one with hemoglobin Ypsilanti.

K P Glynn, J A Penner, J R Smith, D L Rucknagel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5687529     DOI: 10.7326/0003-4819-69-4-769

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Haemoglobin Rahere (beta Lys-Thr): A new high affinity haemoglobin associated with decreased 2, 3-diphosphoglycerate binding and relative polycythaemia.

Authors:  P A Lorkin; A D Stephens; M E Beard; P F Wrigley; L Adams; H Lehmann
Journal:  Br Med J       Date:  1975-10-25

2.  Hemoglobin Malmö Beta-97 (FG-4) histidine--glutamine: a cause of polycythemia.

Authors:  S H Boyer; S Charache; V F Fairbanks; J E Maldonado; A Noyes; E E Gayle
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

3.  Hemoglobin Syracuse (alpha2beta2-143(H21)His leads to Pro), a new high-affinity variant detected by special electrophoretic methods. Observations on the auto-oxidation of normal and variant hemoglobins.

Authors:  M Jensen; F A Oski; D G Nathan; H F Bunn
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

4.  Hemoglobin brigham (alpha2Abeta2100 Pro--Leu). Hemoglobin variant associated with familial erythrocytosis.

Authors:  J J Lokich; W C Moloney; H F Bunn; S M Bruckheimer; H M Ranney
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

5.  Restoring allosterism with compensatory mutations in hemoglobin.

Authors:  H W Kim; T J Shen; D P Sun; N T Ho; M Madrid; M F Tam; M Zou; P F Cottam; C Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

6.  Haemoglobinopathia Ypsilanti - A rare, but important differential diagnosis to polycythaemia vera.

Authors:  Marietta Nygaard; Jesper Petersen; Ole W Bjerrum
Journal:  Leuk Res Rep       Date:  2013-10-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.